resisttb
- Oct 12, 2022
- 1 min read

MSF warns that supply delays of critical TB test will cost lives

The Stop TB Partnership's Global Drug Facility (GDF) communicated on the 14 September 2022 that there could be significant supply delays of the critical GeneXpert TB test due to production constraints by Cepheid, the US based corporation that produces the test. The communication says that the delays are caused by COVID supply chain challenges and an increasing demand for GeneXpert TB tests. Countries placing larger orders may face delays of up to 6 months. The backlog of orders for TB tests is expected to last through March 2023. GDF facilitates global access to quality-assured TB diagnostics and treatments through a one-stop procurement and supply mechanism for national TB programs. Read more here.

Recent Posts

See All

endTB Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options

Clinical trial results presented for the first time at the Union World Conference on Lung Health revealed evidence to support the use of four new, improved regimens to treat multi-drug resistant tuber

New preventive treatment for children cuts the risk of drug-resistant tuberculosis by more than half

Clinical trial results presented in Paris at the Union World Conference on Lung Health showed that a once-daily dose of a widely available antibiotic over six months cut a child’s risk of developing m

Ending TB Is Within Reach — So Why Are Millions Still Dying?

Tuberculosis, which is preventable and curable, has reclaimed the title of the world’s leading infectious disease killer, after being supplanted from its long reign by Covid-19. But worldwide, 40 perc